Archives

by in
Entry Author Date Location
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Vertex Sells Hep C Drug Royalty Rights to Janssen for $152M 11/20/13 Boston
How Alkermes Survived a Brush With Death 11/11/13 National
Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop 10/29/13 Boston
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
Clovis Oncology CEO Mahaffy Opens Up About Company’s Turbulent Year 10/17/13 Boulder/Denver
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
Gilead Climbs on More Good News for Cancer Drug From Seattle 10/10/13 Seattle
The Best Biotech Graduate Schools in Real Life 09/23/13 National
Gilead Seeks FDA OK for Lymphoma Drug, First Big Move into Cancer 09/11/13 San Francisco
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Vertex Sees Liver Toxicity With Emerging Hep C Drug, Faces FDA Hold 07/25/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Sangamo in Race to Replace Chronic Drug Treatment with Gene Therapies 07/15/13 San Francisco
Why I Won’t Cheer If Onyx Pharma Is Sold for Megabucks 07/15/13 National
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
ASCO Wrap-Up: Cancer News from the East, South, & Rockies 06/05/13 National
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections 05/22/13 Seattle
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
Pfizer Yields to Rivals in Hep C Drug Race 03/13/13 New York
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Hepatitis C Treatments from Gilead, Abbott Wow Liver Meeting 11/13/12 Boston
Page 2 of 6 « previous page · next page »